Blueshift Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-988
Closed -$301K 543
2025
Q1
$301K Buy
+988
New +$332K 0.12% 262
2024
Q4
Sell
-2,326
Closed -$776K 457
2024
Q3
$776K Buy
+2,326
New +$884K 0.19% 128
2023
Q4
Sell
-1,350
Closed -$327K 331
2023
Q3
$327K Buy
+1,350
New +$345K 0.19% 166
2023
Q2
Sell
-1,121
Closed -$211K 431
2023
Q1
$211K Buy
+1,121
New +$232K 0.09% 297
2021
Q3
Sell
-1,288
Closed -$227K 1179
2021
Q2
$227K Sell
1,288
-76
-6% -$13.1K 0.01% 816
2021
Q1
$224K Buy
+1,364
New +$209K 0.02% 737
2020
Q3
Sell
-2,603
Closed -$242K 708
2020
Q2
$242K Buy
+2,603
New +$221K 0.04% 443
2019
Q1
Sell
-6,995
Closed -$370K 850
2018
Q4
$370K Buy
+6,995
New +$384K 0.07% 425

Other funds holding MEDP

Blueshift Asset Management's MEDP Position: Q2 2025 in Review

Blueshift Asset Management sold out of Medpace (MEDP) in Q2 2025, closing a stake of 988 shares — an estimated $301K sold.

Blueshift Asset Management first reported a position in MEDP in Q4 2018 and held it in 8 quarters. The position peaked at $776K in Q3 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Blueshift Asset Management reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 988 Medpace shares in Q2 2025, an estimated $301K.
  • Blueshift Asset Management first reported a position in Medpace in Q4 2018 and held it in 8 quarters.
  • Blueshift Asset Management's Medpace position peaked at $776K in Q3 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.